Close Menu
    What's Hot

    The Structural Decision for Setting Up a Life Settlement Vehicle in Ireland

    September 23, 2026
    Litigation

    Litigation Update: U.S. Bank National Association v. Pacific Life Insurance Company

    September 23, 2026

    Q&A: Beat Hess, Managing Partner, AA-Partners

    September 23, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Pacific Life Re Executes First Asset-Intensive Reinsurance Transaction in Hong Kong

      September 9, 2026

      Bermuda Life & Annuity Sidecar Market Quadruples as Alternative Asset Manager/Life Insurance Convergence Continues

      September 9, 2026

      New Report Suggests Global Life/Annuity Reinsurers Poised for Steady Growth

      August 27, 2026

      Pacific Life Re Completes Third Asset-Intensive Flow Reinsurance Transaction in Japan

      August 19, 2026

      US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

      August 13, 2026

      Shaping the Future of Health Insurance Through Innovation and Analytics

      June 10, 2026

      Q&A: Dr Christoph Schmitt, Director, Insurance, Fitch Ratings

      May 28, 2026

      Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

      May 13, 2026

      US Pension Risk Transfer Transactions Up, Aggregate Premium Down in Second Quarter

      September 21, 2026
      Just Group

      Engineering Council Pension Scheme Completes Bulk Purchase Annuity Buy-Out With Just Group

      September 16, 2026

      Special Melted Products Pension Scheme Completes Bulk Purchase Annuity Transaction With Canada Life

      September 15, 2026

      M&G Completes Bulk Purchase Annuity Transaction in Financial Services Industry

      September 14, 2026

      Record Low Mortality Rates So Far in England and Wales in 2026

      July 9, 2026

      Organ Transplant Improvements Test Life Expectancy Assessment Models

      July 8, 2026

      The Pursuit of Everlasting Life Unlikely to Shift Actuarial Models

      June 10, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026

      The Structural Decision for Setting Up a Life Settlement Vehicle in Ireland

      September 23, 2026
      Litigation

      Litigation Update: U.S. Bank National Association v. Pacific Life Insurance Company

      September 23, 2026

      Q&A: Beat Hess, Managing Partner, AA-Partners

      September 23, 2026

      Awareness Raising is More Than Just a One-Month Campaign for Life Settlement Market

      September 9, 2026

      The Structural Decision for Setting Up a Life Settlement Vehicle in Ireland

      September 23, 2026
      Litigation

      Litigation Update: U.S. Bank National Association v. Pacific Life Insurance Company

      September 23, 2026

      Q&A: Beat Hess, Managing Partner, AA-Partners

      September 23, 2026

      US Pension Risk Transfer Transactions Up, Aggregate Premium Down in Second Quarter

      September 21, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 9, September 2026

      September 9, 2026

      Editor’s Letter – Volume 2, Issue 8, August 2026

      August 12, 2026

      Editor’s Letter – Volume 2, Issue 7, July 2026

      July 8, 2026

      Editor’s Letter – Volume 2, Issue 6, June 2026

      June 10, 2026

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    Q&A: Hanna Persson, Head of Sales, Ress Capital

    Secondary Life Markets April 13, 2023By Greg Winterton
    Life Risk News Q&A
    Share
    Twitter LinkedIn Email

    Stockholm-based asset manager Ress Capital is a specialist investor in life settlements and runs one of the few listed vehicles active in the space. Greg Winterton spoke to Hanna Persson, Head of Sales at Ress Capital, to learn more about the firm itself and its approach to the space.

    GW: Hanna, Ress Capital’s investment vehicle is publicly listed, on the Nasdaq Nordic exchange. Why did the firm decide to go that route?

    HP: The open-ended structure enables gradual growth, and policies can be gradually sourced. It also allows the fund to buy longer life expectancies which a closed-end fund could not do with a buy and hold strategy. We wanted to make this very interesting asset class more accessible to investors that would not necessarily be able to invest in the life settlement market otherwise. Being listed allows different type of investors from all over the world to buy shares easily through their local bank/broker.

    GW: Tell us about your approach to policy selection. What are some of the features that you look for in policies that make it into your portfolio, and why?

    HP: In the end, using correct mortality assumptions will of course be most important and we tend to be on the conservative side there. But for policy selection, our investment team focuses on limiting the tail risk of the portfolio both at an individual policy as well as portfolio level. This is achieved by reviewing large numbers of policies and then buying single, high-quality policies. We are very selective and buy only 3-4% of the policies we look at.

    Hannah Persson
    Hanna Persson

    In general, we look for wealthier and relatively healthy individuals with long life expectancies (average life expectancy at purchase is 12 years) which we believe are more accurate. Then, by looking for stable future premium streams, the negative effect of any individual substantially outliving their life expectancy is reduced.

    At a portfolio level, we then always strive to have high level of diversification in terms of age, gender, size and life expectancy which should reduce the systemic risk of medical underwriters estimating longevity for sub-groups.

    GW: Ress Capital is a signatory to the United Nations’ Principles for Responsible Investments. Why did you decide to pursue this credential and what’s been the main benefit so far?

    HP: Being a responsible investor is an integral part of how we operate. Our clients should feel confident that we prioritise sustainability in our daily activities and that we always strive to improve our sustainability efforts. Being an alternative investment manager active in the secondary market for US life insurance policies, ethics is a key aspect.

    At Ress Capital, we are convinced that the future challenges we face will place new demands on us as managers of our clients’ capital. Through our work with responsible investments, we want to contribute to a more long-term and sustainable investment climate where environmental, social, and corporate governance (ESG) factors are included in the investment process. Responsible investments thus become an important prerequisite for achieving our goal of generating good long-term returns.

    As an essential part of Ress Capital’s commitment to sustainability and responsible investments, we signed the United Nations’ Principles of Responsible Investment (UNPRI) in 2017 meaning we supports the work carried out by UNPRI to promote sustainability work in the asset management industry.

    GW: There is disagreement amongst life settlement-focused investment managers about whether the asset class should be considered more akin to private equity or alternative credit. What’s Ress Capital’s view and why?

    HP: I wouldn’t say Ress Capital has taken any official stance on this. However, we believe the asset class potentially has similarities with alternative credit, although we would argue that the credit rating of US life insurance companies is far better and they’re also highly regulated. As regards similarities with private equity, since our fund is listed, it has little in common with closed-end PE funds with no liquidity. Also, we would argue that expected return profile is quite different from PE. 

    GW: Lastly, Hanna, what’s your message to institutional, end investors that don’t have an allocation to life settlements in their portfolio – what are the main reasons for doing so in your view?

    HP: This is an asset class that is fundamentally uncorrelated to majority of other asset classes. The underlying risk is decoupled from the economic cycle. When done correctly, life settlements as an asset class offers a fixed income alternative with yields comparable to those of an equity portfolio, but with volatility below that of investment grade bonds. In times of high volatility in the market life settlements present a unique, stable and truly uncorrelated return stream.

    Hanna Persson is Head of Sales at Ress Capital

    2023 - April Life Settlements Longevity Risk Q&A Volume 2 Issue 4 - April 2023
    Share. Twitter LinkedIn Email

    Related Posts

    The Structural Decision for Setting Up a Life Settlement Vehicle in Ireland

    September 23, 2026By Greg Winterton

    Q&A: Beat Hess, Managing Partner, AA-Partners

    September 23, 2026By Greg Winterton

    Awareness Raising is More Than Just a One-Month Campaign for Life Settlement Market

    September 9, 2026By Greg Winterton

    AM Best Requests Comments on Proposed Revisions to Life Settlement Securitisation Criteria

    September 9, 2026By LMI Newsdesk
    Latest Issue

    Awareness Raising is More Than Just a One-Month Campaign for Life Settlement Market

    September 9, 2026

    Slowing US PRT Market Sees Insurers Jostling for Business as Buy-Ins Surge

    September 9, 2026

    Bermuda Life & Annuity Sidecar Market Quadruples as Alternative Asset Manager/Life Insurance Convergence Continues

    September 9, 2026

    Insurers Sweeten Bulk Purchase Annuity Offers as Buy-Out Timetables – and Costs – Look Set To Increase

    August 26, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.